Technology | March 28, 2016

Merge Offers an Integrated CVIS

Merge Healthcare, an IBM company, offers award-winning cardiology and hemodynamics solutions that provide a complete view of patient records, access to reporting tools, and integrate with the largest health information systems to enable interoperable image exchange. At the American College opf Cardiology (ACC) 2016 annual meeting, Merge (booth 20,046) will demonstrate how its cardiology solutions can integrate data collection, inventory control, patient billing, and procedure reporting into a single platform, providing a complete, end-to-end cardiology imaging strategy.

Related Content

Results from the IVUS-DCB trial were recently presented at the American College of Cardiology Annual Scientific Session, ACC.24.
News | ACC
Intravascular Ultrasound Outperforms Angiography for Peripheral Artery Disease Treatment

April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...

Home April 11, 2024
Home
The Minneapolis Heart Institute Foundation (MHIF) is presenting data on trends in ST-elevation myocardial infarction (STEMI) at the American College of Cardiology’s Annual Scientific Session (ACC.24). An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovascular disease.
News | ACC
Research Data from Minneapolis Heart Institute Foundation at ACC 2024 Reveal Trends in Cardiovascular Risk Factors and Preventive Medication Use Prior to Heart Attacks

April 6, 2024 — The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST ...

Home April 06, 2024
Home
In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization, the American College of Cardiology (ACC) has planned a full range of educational programming, special events and peer networking scheduled throughout the April 6-8 event in Atlanta, GA. 
Feature | ACC | Christine Book
American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization ...

Home April 03, 2024
Home
Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II-III obstructive hypertrophic cardiomyopathy at the American College of Cardiology (ACC) Annual Scientific Session & Expo, ACC.24, taking place April 6-8, 2024 in Atlanta, Georgia.
News | ACC
Bristol Myers Squibb to Present Data on CAMZYOS (mavacamten) for obstructive hypertrophic cardiomyopathy (HCM) at American College of Cardiology Annual Scientific Session, ACC.24

March 26, 2024 — Bristol Myers Squibb has announced that it will present data on CAMZYOS (mavacamten) for NYHA class II ...

Home March 26, 2024
Home
Here is a look at the education and special events planned for the ACC24 73rd Annual Scientific Session & Expo, April 6-8 in Atlanta
Feature | ACC | By Melinda Taschetta-Millane
American College of Cardiology (ACC24) Show Preview: Advancing Cardiovascular Care for All

The American College of Cardiology (ACC) has announced key educational and programming highlights for its ACC 73rd ...

Home March 25, 2024
Home
Association Between Prognostic Implications of Platelet FCɣRIIA (PFCG) and Treatment Strategy for Myocardial Infarction
News | ACC
Prolocor to Present New Clinical Evidence at ACC 24 Supporting the Use of PLATELET FCÉŁRIIA (PFCG) as a Key Tool in Individualizing Dual Antiplatelet Therapy (DAPT)

March 21, 2024 — Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the goal ...

Home March 21, 2024
Home
The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd Annual Scientific Session & Expo, ACC.24, including U.S. Food and Drug Administration Commissioner Robert M. Califf, MD, MACC, among a host of highly-regarded cardiovascular thought leaders and practitioners during the April 6-8 meeting in Atlanta, GA.
News | ACC
FDA Commissioner, Host of Cardiovascular Leaders to Offer Keynote Addresses at ACC.24

March 7, 2024 — The American College of Cardiology (ACC) has announced its line-up of keynote speakers for the ACC 73rd ...

Home March 07, 2024
Home
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
News | ACC
American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific Session ...

Home February 29, 2024
Home
NCDR’s CV ASC Registry Suite follows increases in ambulatory cardiac procedures, provides benchmarks
News | ACC
First-of-its-kind ACC Registry Tracks Cardiac Procedures Performed in Ambulatory Surgical Settings

February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac ...

Home February 14, 2024
Home
This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022.
News | ACC
CTA and ACC Collaborate to Tackle Cardiovascular Disease with Technology

February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing ...

Home February 07, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now